Psilera Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Psilera Inc.
Quantité totale PI 13
Rang # Quantité totale PI 123 355
Note d'activité PI 2/5.0    13
Rang # Activité PI 68 833
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

4 2
2 0
5 0
0
 
Dernier brevet 2025 - 5-ht2a receptor ligands
Premier brevet 2021 - Novel compositions of matter and...
Dernière marque 2022 - PSILERA
Première marque 2021 - PSILERA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Compositions of matter and pharmaceutical compositions. Pharmaceutical formulations of novel ind...
Invention Formulations containing tryptamine derivatives and uses thereof
Invention Formulations containing tryptamine derivatives and uses thereof. Pharmaceutical compositions that...
2023 Invention 5-ht2a receptor ligands. 5-HT2A receptor ligands and receptor-ligand complexes are synthesized. ...
Invention 5-ht2a receptor ligands. 5-HT2A receptor ligands and receptor-ligand complexes are synthesized. T...
2022 Invention Modified indole compounds. Novel compounds are provided. The compounds are modified at the four ...
Invention N,n-dimethyltryptamine (dmt) crystalline products and methods of making the same. N,NN,N-Dimethyl...
Invention Modified indole compounds. Novel compounds are provided. The compounds are modified at the four p...
P/S Drug discovery services; Clinical research in the field of neurological disorders; Clinical resea...
2021 Invention Novel compositions of matter and pharmaceutical compositions. Pharmaceutical formulations of nove...
Invention Compositions of matter and pharmaceutical compositions. Pharmaceutical formulations of novel indo...
P/S Pharmaceutical preparations for the treatment of Alzheimer's disease; Pharmaceutical preparations...